Skip to content

APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation

APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05579678
Acronym
APOLLO
Enrollment
45
Registered
2022-10-14
Start date
2022-11-20
Completion date
2026-08-31
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allogeneic Disease

Brief summary

People who undergo allogeneic bone marrow transplant for blood cancers receive the highest chemotherapy doses possible that humans can receive and still survive. As a result, they have devastating side effects during the procedure and for many years afterwards. Damage to organs and muscles cause long-lasting physical weakness and the psychological experience is severe enough to be termed 'post traumatic stress disorder' that also lasts for many years. These effects are worsened by the fact that most Canadians live several hours away from treatment and transplant centers, leaving them entirely on their own to manage these difficult long term effects. The APOLLO team will perform a qualitative study to learn the experiences of people undergoing allogeneic bone marrow transplant while they receive access to a supportive care computer 'app' and telephone support from nursing, exercise and nutrition experts. In this way, the APOLLO team will learn the most helpful type and timing of supportive care from those who know best.

Interventions

BEHAVIORALSupportive nursing, nutritional and physical activity with a handheld 'app'

Supportive nursing, nutritional and physical activity with a handheld 'app'

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* eligible for allogeneic transplantation

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Title: Acceptability of a multimodal supportive care1 yearDescription: Questionnaire to assess usefulness of a multimodal supportive care App that includes care navigation (nursing, exercise, nutrition)

Countries

Canada

Contacts

CONTACTEdith Pituskin, PhD
pituskin@ualberta.ca7804328221

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026